We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+9.43%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$230B
AUM Growth
+$18.4B
Cap. Flow
-$8.18B
Cap. Flow %
-3.55%
Top 10 Hldgs %
23.04%
Holding
10,299
New
1,220
Increased
3,476
Reduced
4,117
Closed
1,266

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$615M
2
UBER icon
Uber
UBER
+$551M
3
EXPE icon
Expedia Group
EXPE
+$523M
4
PYPL icon
PayPal
PYPL
+$452M
5
ETN icon
Eaton
ETN
+$408M

Sector Composition

Rank Sector Weight
1 Technology 5.14%
2 Financials 4.52%
3 Industrials 4.17%
4 Healthcare 3.91%
5 Consumer Discretionary 3.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OCUL icon
8551
CALL
Ocular Therapeutix
OCUL
$1.92B
$54K ﹤0.01%
13,600
-10,600
-44% -$36.9K
EIGI
8552
DELISTED
Endurance International Group Holdings, Inc.
EIGI
$54K ﹤0.01%
11,573
-271,354
-96% -$1.11M
ENT
8553
DELISTED
Global Eagle Entertainment Inc.
ENT
$54K ﹤0.01%
4,298
+249
+6% +$3.42K
CLSD
8554
PUT
DELISTED
Clearside Biomedical
CLSD
$53K ﹤0.01%
+1,213
New +$25.5K
CVV icon
8555
CVD Equipment Corp
CVV
$57.9M
$53K ﹤0.01%
+16,539
New +$57.6K
EGY icon
8556
Vaalco Energy
EGY
$552M
$53K ﹤0.01%
+23,777
New +$47.1K
KODK icon
8557
CALL
Kodak
KODK
$925M
$53K ﹤0.01%
11,400
-7,900
-41% -$21.9K
VERU icon
8558
Veru
VERU
$37.1M
$53K ﹤0.01%
1,574
+229
+17% +$5.11K
TOO
8559
DELISTED
Teekay Offshore Partners L.P.
TOO
$53K ﹤0.01%
34,634
-24,432
-41% -$37.6K
ASRT
8560
CALL
DELISTED
Assertio
ASRT
$52K ﹤0.01%
692
-145
-17% -$8.5K
BCLI
8561
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$52K ﹤0.01%
+816
New +$47.3K
SCOR icon
8562
PUT
Comscore
SCOR
$113M
$52K ﹤0.01%
+530
New +$36.2K
TRAK icon
8563
ReposiTrak
TRAK
$158M
$52K ﹤0.01%
+10,282
New +$52.8K
TTOO
8564
DELISTED
T2 Biosystems, Inc
TTOO
$52K ﹤0.01%
9
+6
+200% +$56.7K
GER
8565
DELISTED
Goldman Sachs MLP Energy Renaissance Fund
GER
$52K ﹤0.01%
1,350
-201
-13% -$7.96K
QTT
8566
CALL
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
$52K ﹤0.01%
1,530
-580
-27% -$19.3K
OTIC
8567
DELISTED
Otonomy, Inc.
OTIC
$52K ﹤0.01%
+13,472
New +$32.9K
LEAF
8568
DELISTED
Leaf Group Ltd.
LEAF
$52K ﹤0.01%
+12,986
New +$47.8K
ACRS icon
8569
Aclaris Therapeutics
ACRS
$851M
$51K ﹤0.01%
26,771
-47,963
-64% -$79.5K
LSAK icon
8570
PUT
Lesaka Technologies
LSAK
$403M
$50K ﹤0.01%
+13,400
New +$44.4K
SNCR
8571
CALL
DELISTED
Synchronoss Technologies
SNCR
$50K ﹤0.01%
+1,178
New +$52.3K
TXMD icon
8572
CALL
TherapeuticsMD
TXMD
$24.2M
$50K ﹤0.01%
412
-226
-35% -$32.5K
CTST
8573
DELISTED
CannTrust Holdings Inc. Common Share
CTST
$50K ﹤0.01%
+53,578
New +$53.3K
CEMI
8574
DELISTED
Chembio diagnostics, Inc.
CEMI
$50K ﹤0.01%
+11,019
New +$53.7K
NES
8575
DELISTED
Nuverra Environmental Solutions, Inc. Common Stock
NES
$50K ﹤0.01%
17,429
+5,548
+47% +$17.7K

Similar funds

Citadel Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Citadel Advisors held 10,299 positions worth $230B, up 8.7% from $212B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Citadel Advisors withdrew a net $8.18B in Q4 2019, closing 1,266 positions and reducing 4,117 holdings. Its most notable exit was Celgene Corp, an estimated $681M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.1% of assets, down from 5.3% a quarter earlier, followed by Financials and Industrials.

Against the trend, Citadel Advisors opened a new position in Interxion Holding N.V. worth $83.9M.

  • Citadel Advisors's largest Q4 2019 buy was Interxion Holding N.V.: 1,000,931 shares worth $83.9M.
  • Citadel Advisors added most to Amazon in Q4 2019, an estimated $615M increase.
  • Citadel Advisors's biggest Q4 2019 reduction was Raytheon Company, cutting an estimated $543M.
  • Citadel Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $681M.
  • Citadel Advisors's ten largest holdings make up 23% of its $230B portfolio in Q4 2019.
  • Citadel Advisors opened 1,220 new positions and closed 1,266 in Q4 2019.
  • Citadel Advisors's portfolio value rose 8.7% quarter-over-quarter to $230B.

Based on Citadel Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.